Skip to main content

Advertisement

Log in

Effects of cardiac resynchronization therapy on ventricular remodeling

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Remodeling reflects the structural and functional deterioration that occurs in heart failure. Indices of remodeling constitute an important marker of the severity of heart failure, and reverse remodeling is an accepted goal in the treatment of heart failure. Cardiac resynchronization therapy (CRT) has been shown to reverse the remodeling process by improving ventricular size, shape, and mass and reducing mitral regurgitation in the short and long term. Diastolic function, right ventricular size, and atria exhibit reverse remodeling. Trials of medical therapy for heart failure strongly link remodeling indices with outcomes, and emerging data suggest that remodeling indices may be among the most accurate predictors of long-term morbidity and mortality in heart failure patients with CRT devices. This review discusses remodeling and focuses on the evidence for CRT-induced reverse remodeling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al.: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003, 289:194–202.

    Article  PubMed  Google Scholar 

  2. Rosamond W, Flegal K, Friday G, et al.: Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69–e171. [Published erratum appears in Circulation 2007, 115:e172.]

    Article  PubMed  Google Scholar 

  3. Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709–717.

    Article  PubMed  CAS  Google Scholar 

  4. Douglas PS, Morrow R, Ioli A, Reichek N: Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989, 13:311–315.

    PubMed  CAS  Google Scholar 

  5. Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA: Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol 1992, 19:1136–1144.

    Article  PubMed  CAS  Google Scholar 

  6. Vasan RS, Larson MG, Benjamin EJ, et al.: Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997, 336:1350–1355.

    Article  PubMed  CAS  Google Scholar 

  7. White HD, Norris RM, Brown MA, et al.: Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987, 76:44–51.

    PubMed  CAS  Google Scholar 

  8. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877–883.

    Article  PubMed  Google Scholar 

  9. St John Sutton MG, Plappert T, Abraham WT, et al.: Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003, 107:1985–1990.

    Article  PubMed  Google Scholar 

  10. He S, Fontaine AA, Schwammenthal E, et al.: Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation 1997, 96:1826–1834.

    PubMed  CAS  Google Scholar 

  11. Lancellotti P, Gerard PL, Pierard LA: Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005, 26:1528–1532.

    Article  PubMed  Google Scholar 

  12. St John Sutton M, Pfeffer MA, Moye L, et al.: Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 1997, 96:3294–3299.

    PubMed  CAS  Google Scholar 

  13. Pfeffer MA, Braunwald E, Moye LA, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992, 327:669–677.

    PubMed  CAS  Google Scholar 

  14. Konstam MA, Rousseau MF, Kronenberg MW, et al.: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 1992, 86:431–438.

    PubMed  CAS  Google Scholar 

  15. Rahmouni H, Plappert T, St John Sutton M: Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy. In Cardiac Resynchronization Therapy. Edited by St John Sutton M, Bax J, Jessup M, et al.: New York: Informa Health Care; 2007:71–84.

    Google Scholar 

  16. Yu CM, Chau E, Sanderson JE, et al.: Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002, 105:438–445.

    Article  PubMed  Google Scholar 

  17. Kass DA, Chen CH, Curry C, et al.: Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999, 99:1567–1573.

    PubMed  CAS  Google Scholar 

  18. Kanzaki H, Bazaz R, Schwartzman D, et al.: A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 2004, 44:1619–1625.

    Article  PubMed  Google Scholar 

  19. Sutton MG, Plappert T, Hilpisch KE, et al.: Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 2006, 113:266–272.

    Article  PubMed  Google Scholar 

  20. Tei C, Ling LH, Hodge DO, et al.: New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy. J Cardiol 1995, 26:357–366.

    PubMed  CAS  Google Scholar 

  21. Cappola TP, Harsch MR, Jessup M, et al.: Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender. J Card Fail 2006, 12:182–188.

    Article  PubMed  CAS  Google Scholar 

  22. Bleeker GB, Schalij MJ, Nihoyannopoulos P, et al.: Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol 2005, 46:2264–2269.

    Article  PubMed  Google Scholar 

  23. Yu CM, Fang F, Zhang Q, et al.: Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure. J Am Coll Cardiol 2007, 50:778–785.

    Article  PubMed  Google Scholar 

  24. Abraham WT, Hayes DL: Cardiac resynchronization therapy for heart failure. Circulation 2003, 108:2596–2603.

    Article  PubMed  Google Scholar 

  25. Linde C, Leclercq C, Rex S, et al.: Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 2002, 40:111–118.

    Article  PubMed  Google Scholar 

  26. Cleland JG, Daubert JC, Erdmann E, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539–1549.

    Article  PubMed  CAS  Google Scholar 

  27. Gasparini M, Bocchiardo M, Lunati M, et al.: Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: the Bi vs Left Ventricular Pacing: an International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J 2006, 152:155.e1–155.e7.

    Article  Google Scholar 

  28. Van Gelder BM, Bracke FA, Van Der Voort PH, Meijer A: Optimal sensed atrio-ventricular interval determined by paced QRS morphology. Pacing Clin Electrophysiol 2007, 30:476–481.

    Article  PubMed  Google Scholar 

  29. Gold MR, Niazi I, Giudici M, et al.: A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2007, 18:490–496.

    Article  PubMed  Google Scholar 

  30. Kedia N, Ng K, Apperson-Hansen C, et al.: Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy. Am J Cardiol 2006, 98:780–785.

    Article  PubMed  Google Scholar 

  31. Porciani MC, Dondina C, Macioce R, et al.: Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy. J Card Fail 2006, 12:715–719.

    Article  PubMed  Google Scholar 

  32. Morales MA, Startari U, Panchetti L, et al.: Atrioventricular delay optimization by doppler-derived left ventricular dP/dt improves 6-month outcome of resynchronized patients. Pacing Clin Electrophysiol 2006, 29:564–568.

    Article  PubMed  Google Scholar 

  33. Stockburger M, Fateh-Moghadam S, Nitardy A, et al.: Optimization of cardiac resynchronization guided by Doppler echocardiography: haemodynamic improvement and intraindividual variability with different pacing configurations and atrioventricular delays. Europace 2006, 8:881–886.

    Article  PubMed  Google Scholar 

  34. Gasparini M, Auricchio A, Regoli F, et al.: Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006, 48:734–743.

    Article  PubMed  Google Scholar 

  35. Beshai JF, Grimm RA, Nagueh SF, et al: Cardiac resynchronization in heart failure with narrow QRS complexes. N Engl J Med 2007, 357:2461–2471.

    Article  PubMed  CAS  Google Scholar 

  36. Ghio S, Leon A, et al.: Predictors of response to resynchronization therapy. Presented at the European Society of Cardiology Congress 2007. Vienna; September 1–5, 2007.

  37. Bleeker GB, Mollema SA, Holman ER, et al.: Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation 2007, 116:1440–1448.

    Article  PubMed  Google Scholar 

  38. Yu CM, Bleeker GB, Fung JW, et al.: Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005, 112:1580–1586.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin G. St. John Sutton.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rahmouni, H.W., Kirkpatrick, J.N. & St. John Sutton, M.G. Effects of cardiac resynchronization therapy on ventricular remodeling. Curr Heart Fail Rep 5, 25–30 (2008). https://doi.org/10.1007/s11897-008-0005-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-008-0005-1

Keywords

Navigation